Every peptide, graded by the evidence — not the hype.
A verified, plain-English reference for clinical peptides and metabolic therapies: regulatory status, human-trial data, and a tier rating for each compound. Built for providers and the patients they treat.
Three tiers. Four evidence grades. No marketing.
Every compound is sorted by its real regulatory standing and the strength of the human data behind it — so a provider can see in two seconds where a therapy actually stands.
FDA-approved / recognized
Approved products, or substances with established human-trial support. Prescribe and compound within the normal rules.
22 compounds in this tierCompoundable · emerging data
Lawfully compoundable under 503A/503B with a legitimate evidence base, but outside a full FDA approval. Use with informed consent.
5 compounds in this tierInformation only
Research compounds with thin or preclinical-only human data, or an unsettled compounding status. Documented here for transparency — not a recommendation.
47 compounds in this tierBrowse the compound index
Each profile carries the tier, the evidence grade, mechanism, regulatory status across jurisdictions, and every human study we could verify — cited to PubMed.
Tesamorelin
Stabilized GHRH(1-44).
Semaglutide
GLP-1R agonist; t½ ~7 d (SC weekly); oral formulation with SNAC.
Tirzepatide
Dual GIP/GLP-1R agonist; t½ ~5 d.
Sermorelin
GHRH-R agonist, t½ minutes.
BPC-157
Proposed NO/VEGF/growth-factor effects; rodent data.
CJC-1295
Albumin-binding GHRH; t½ ~6-8 d.
Compounding, in plain terms
Peptide legality turns on one framework most patients have never heard of. Here's the short version — the long version lives on every compound page.
503A pharmacies
Compound patient-specific prescriptions. A peptide has to sit on an approved bulks list — or be an approved drug — to be made here legally. We flag each compound's 503A standing.
503B outsourcing facilities
Make larger batches under FDA cGMP oversight for office use. Different list, different rules — a compound can qualify for one lane and not the other.
Evidence grade A–D
Separate from legality: how good is the human data? Grade A is RCT-backed; D is mechanism or anecdote. Legal to compound and well-studied are not the same thing — we show both.
A fast reference — and the door to your portal.
Register your practice, then use 503MD to look things up and jump straight to your portal — where your orders from LocumTele and Virtual ClinicOS live in one place. Connecting your patients to NewStartMD is optional, never required to order.
- Verified licensure, once
- One portal for LocumTele or Virtual ClinicOS — or both
- Evidence-graded formulary built in
- 503A / 503B status on every compound